Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty.

@article{Tsuchikane1999ImpactOC,
  title={Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty.},
  author={Etsuo Tsuchikane and Akinori Fukuhara and Tohru Kobayashi and Motohiro Kirino and Kouichi Yamasaki and Masahiro Izumi and Satoru Otsuji and Hitone Tateyama and Makoto Sakurai and Nobuhisa Awata},
  journal={Circulation},
  year={1999},
  volume={100 1},
  pages={21-6}
}
BACKGROUND Restenosis after percutaneous transluminal coronary (balloon) angioplasty (PTCA) remains a major drawback of the procedure. We previously reported that cilostazol, a platelet aggregation inhibitor, inhibited intimal proliferation after directional coronary atherectomy and reduced the restenosis rate in humans. The present study aimed to determine the effect of cilostazol on restenosis after PTCA. METHODS AND RESULTS Two hundred eleven patients with 273 lesions who underwent… CONTINUE READING